Recent Funding
Investors
Frazier Healthcare Partners

Frazier Healthcare Partners portfolio

Frazier Healthcare Partners has 2 portfolio companies on record at Recent Funding.

Website: frazierhealthcare.com.

Type: Private equity.

Portfolio on Recent Funding: 2.

Deals, last 12 months: 0.

Rounds led: 1 of 2.

Capital in their rounds: $101M.

Latest deal: Lassen Therapeutics · Jun 17, 2020.

About this page

It is a private equity firm based in Seattle, US, founded in 1991. It led 1 of the 2 rounds it joined. Its most recent investment on record is Lassen Therapeutics's $31M Series A round in June 2020, which it led, alongside Longwood Fund and Alta Partners. By category, its portfolio leans toward Health and bio (2). It has co-invested with Longwood Fund, Alta Partners and S32.

About Frazier Healthcare Partners

Firm type: Private equity.

Headquarters: Seattle, US.

Founded: 1991.

Stages: Growth.

Sectors: Biotech, Digital Health, FemTech, Healthtech, Medical Devices, Wellness & Fitness.

Check size: $50M to $400M.

Portfolio companies: 70.

Exits: 13.

Rounds led: 0.

The companies Frazier Healthcare Partners bought, as a private equity firm: Frazier Healthcare Partners acquisitions.

Fund returns

Fund	Vintage	Size	Net IRR	TVPI	DPI	As of
Frazier Life Sciences Public Overage Fund	2022	—	—	1.28x	0.17x	Mar 31, 2025
Frazier Healthcare Ventures V, L.P.	2005	—	14.7%	2.28x	2.28x	Jun 30, 2025
Frazier Healthcare IV, L.P.	2001	—	0.7%	1.00x	1.04x	Sep 30, 2025
Frazier Healthcare III, L.P.	1998	—	-11.1%	0.50x	0.47x	Sep 30, 2025
Frazier Healthcare II, L.P.	1996	—	6.9%	1.50x	1.46x	Sep 30, 2025

What Frazier Healthcare Partners invests in

Health and bio · 2 · 100%

How Frazier Healthcare Partners invests

Stage	Deals	Capital in rounds
Series A	2 100%	$101M

Frazier Healthcare Partners portfolio companies

LLassen Therapeutics$31MSeries A · Jun 2020
AAspen Neuroscience$70MSeries A · Apr 2020

Company	Round with Frazier Healthcare Partners	Total raised	Latest raise
LLassen Therapeutics Health and bio	Jun 17, 2020 Series A · $31M · lead	$116M	Jan 17, 2024 Series B+
AAspen Neuroscience Health and bio	Apr 1, 2020 Series A · $70M	$339M	Nov 20, 2025 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 2 rounds on Recent Funding that name Frazier Healthcare Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Frazier Healthcare Partners, which is a subset of its real portfolio. API: /api/v1/investors/frazier-healthcare-partners (get a free API key). More: the most active VC firms and new venture capital funds.